Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fermentation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106520896B reveals one-step fermentation for 8DM. Enhances yield and reduces solvent use for reliable pharmaceutical intermediates supply chains.
Patent CN114672525A reveals a novel biosynthetic route for N-acetyl-5-methoxytryptamine using engineered E. coli, offering a sustainable alternative to chemical synthesis for pharmaceutical applications.
Patent CN103343155B offers high-yield fermentation for steroid intermediates, reducing costs and improving supply chain reliability for pharmaceutical manufacturing.
Patent CN101948450A reveals advanced fermentation purification for high-purity Orlistat. This method ensures supply chain reliability and significant cost reduction.
Patent CN103642747A details a high-efficiency recombinant E. coli method for chiral alcohol production, offering superior ee >99% and cost-effective cofactor regeneration for pharma supply chains.
Patent CN106191151B reveals a novel biotransformation route for high-purity D-lysine and 5-aminovaleric acid co-production, offering significant supply chain and cost advantages for global manufacturers.
Novel patent CN103965277B enables chromium-free difluprednate production using phytosterols. Enhances supply chain reliability and reduces environmental impact for pharmaceutical manufacturers.
Patent CN102617697A details a novel eplerenone synthesis from androstenedione. This report analyzes the cost reduction and supply chain advantages for pharmaceutical manufacturers.
High-yield microbial conversion method for D-chiro-inositol from myo-inositol. Scalable fermentation process offering cost reduction and supply reliability.
Patent CN1220695A details a microbial process for chiral aminoalcohols, offering a scalable alternative to chemical synthesis for carbocyclic nucleosides.
Patent CN1070686A details microbial nitrile hydration for high-purity amides. This method offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN1224697C reveals a novel microbial process for high-purity aminoalcohols, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Advanced resin-based purification process for pristinamycin offering higher yields and reduced solvent consumption. Ideal for pharmaceutical manufacturers seeking cost-effective supply.
Patent CN102603769A reveals novel sulfur-chromones from Penicillium oxalicum with potent anticancer activity, offering scalable fermentation routes for pharmaceutical intermediates.
Patent CN106520890B reveals a novel two-phase fermentation method using Aspergillus ochraceus for efficient steroid dehydrogenation, offering significant cost reduction in API manufacturing.
Patent CN107058452A reveals novel fermentation route reducing cost and pollution for high-purity steroid intermediates ensuring supply chain stability.
Patent CN107602652A enables high-purity reference substance production for methylprednisolone impurity control and supply chain stability.
Novel E. coli pathway boosts ergothioneine yield. Cost-effective fermentation for nutritional ingredients. Supply chain reliability ensured.
Novel recombinant E. coli strain enables high yield tetrahydropyrimidine secretion reducing purification costs significantly for supply chains.
Patent CN112143688A reveals a novel recombinant E. coli strain for high-purity (S)-CHBE production, offering significant cost reduction in API manufacturing.